News

This article explains how biomarker assay development and validation ensure reliable clinical applications through careful assay design, analytical testing, clinical validation, and regulatory alignment.

In medical device regulation, the adherence to stringent quality management standards is pivotal. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the International Organization for Standardization (ISO) play crucial roles in shaping these standards. A significant framework introduced by the FDA is the Quality Management System Regulation (QMSR), with its alignment with international standards like ISO 13485:2016 emphasized in Document 89 FR 7496. Unp

This article explains verification vs validation in immunoassay and in vitro diagnostics, and why both are essential for assay performance, regulatory compliance, and reliable clinical use.

Bioconjugation is transforming modern medicine by enabling targeted drug delivery and more precise therapeutic interventions. This article outlines how bioconjugation supports applications such as nanoparticles, polymer-drug conjugates, peptide conjugates, and antibody-drug conjugates to improve efficacy, specificity, and safety.

This article explores sensitivity vs specificity in in vitro diagnostics, and how balancing both is critical for test performance, diagnostic accuracy, and reliable clinical decisions.

Quality control in immunoassay development ensures reliable diagnostic results through calibration standards, internal controls, validation studies, and robust assay monitoring.